Ernexa Therapeutics Inc. Security Deposit Liability
Ernexa Therapeutics Inc. (ERNA) had Security Deposit Liability of $63.22 thousand as of 2018-06-14, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities
us-gaap:SecurityDepositLiability · last filed 2021-05-17
- 2018-06-14: Security Deposit Liability $63.22K.
| Period end | Security Deposit Liability |
|---|---|
| 2018-06-14 | $63.22K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |